Ubs Group Ag Immunic, Inc. Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

A detailed history of Ubs Group Ag transactions in Immunic, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 1,354 shares of IMUX stock, worth $1,597. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,354

Previous 9,167 85.23%

Holding current value

$1,597

Previous $12,000 91.67%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.98 - $1.44 $7,656 - $11,250	-7,813 Reduced 85.23%	1,354 $1,000
Q1 2024 May 13, 2024	SELL	$1.14 - $1.53 $1,383 - $1,857	-1,214 Reduced 11.69%	9,167 $12,000
Q4 2023 Feb 09, 2024	BUY	$0.97 - $1.6 $7,078 - $11,675	7,297 Added 236.61%	10,381 $15,000
Q3 2023 Nov 09, 2023	BUY	$1.35 - $2.87 $4,129 - $8,779	3,059 Added 12236.0%	3,084 $4,000
Q2 2023 Aug 11, 2023	SELL	$1.33 - $2.51 $13,296 - $25,092	-9,997 Reduced 99.75%	25 $0
Q1 2023 May 12, 2023	BUY	$1.35 - $2.87 $13,495 - $28,691	9,997 Added 39988.0%	10,022 $14,000
Q4 2022 Feb 08, 2023	SELL	$1.13 - $10.8 $4,234 - $40,467	-3,747 Reduced 99.34%	25 $0
Q3 2022 Nov 10, 2022	SELL	$3.0 - $5.49 $209,379 - $383,163	-69,793 Reduced 94.87%	3,772 $12,000
Q2 2022 Aug 10, 2022	BUY	$3.13 - $12.25 $227,964 - $892,192	72,832 Added 9936.15%	73,565 $255,000
Q1 2022 May 16, 2022	SELL	$9.54 - $14.26 $41,823 - $62,515	-4,384 Reduced 85.68%	733 $8,000
Q4 2021 Feb 14, 2022	BUY	$7.34 - $10.25 $21,425 - $29,919	2,919 Added 132.8%	5,117 $49,000
Q3 2021 Nov 15, 2021	SELL	$8.05 - $13.29 $11,455 - $18,911	-1,423 Reduced 39.3%	2,198 $19,000
Q2 2021 Aug 13, 2021	BUY	$11.76 - $16.85 $42,582 - $61,013	3,621 New	3,621 $44,000
Q4 2020 Feb 11, 2021	SELL	$14.8 - $20.37 $28,904 - $39,782	-1,953 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$11.74 - $22.0 $10,472 - $19,624	892 Added 84.07%	1,953 $36,000
Q2 2020 Jul 31, 2020	SELL	$5.67 - $15.86 $12,139 - $33,956	-2,141 Reduced 66.86%	1,061 $13,000
Q1 2020 May 01, 2020	BUY	$4.22 - $9.8 $13,512 - $31,379	3,202 New	3,202 $19,000
Q3 2019 Nov 14, 2019	SELL	$10.0 - $17.01 $4,290 - $7,297	-429 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$7.88 - $33.2 $3,380 - $14,242	429 New	429 $5,000

Others Institutions Holding IMUX

# of Institutions

Shares Held

56M

Call Options Held

4.7K

Put Options Held

311K

View Full List

About IMMUNIC, INC.

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $36.1M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

More about IMUX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account